Plexus Corp. (NASDAQ:PLXS – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the four research firms that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $107.75.
A number of research analysts have issued reports on the stock. TheStreet lowered shares of Plexus from a “b” rating to a “c+” rating in a research report on Tuesday, February 13th. Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $112.00 target price on the stock. in a research report on Tuesday, January 9th. Stifel Nicolaus increased their target price on shares of Plexus from $90.00 to $95.00 and gave the stock a “hold” rating in a research report on Friday. Needham & Company LLC increased their target price on shares of Plexus from $107.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Benchmark restated a “buy” rating and set a $110.00 target price on shares of Plexus in a research report on Wednesday, January 17th.
Read Our Latest Report on PLXS
Insider Transactions at Plexus
Hedge Funds Weigh In On Plexus
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Parallel Advisors LLC increased its position in Plexus by 72.3% in the 4th quarter. Parallel Advisors LLC now owns 348 shares of the technology company’s stock valued at $38,000 after acquiring an additional 146 shares during the period. GAMMA Investing LLC acquired a new stake in shares of Plexus during the fourth quarter worth $44,000. Cetera Trust Company N.A acquired a new stake in shares of Plexus during the fourth quarter worth $54,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Plexus during the fourth quarter worth $66,000. Finally, Avior Wealth Management LLC acquired a new stake in shares of Plexus during the third quarter worth $91,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.
Plexus Stock Up 1.2 %
Shares of PLXS opened at $100.28 on Friday. Plexus has a 52 week low of $83.84 and a 52 week high of $114.06. The firm has a market cap of $2.77 billion, a P/E ratio of 27.70 and a beta of 1.02. The firm’s 50-day simple moving average is $94.48 and its 200 day simple moving average is $98.44. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.62 and a current ratio of 1.51.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its earnings results on Wednesday, April 24th. The technology company reported $0.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.07. Plexus had a net margin of 2.54% and a return on equity of 10.77%. The firm had revenue of $966.90 million for the quarter, compared to analyst estimates of $950.75 million. During the same quarter in the prior year, the business posted $1.45 EPS. The business’s revenue was down 9.7% compared to the same quarter last year. On average, analysts forecast that Plexus will post 4.36 earnings per share for the current year.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- How Can Investors Benefit From After-Hours Trading
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- How to Start Investing in Real Estate
- MarketBeat Week in Review – 4/22 – 4/26
- Using the MarketBeat Dividend Tax Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.